HATRIC: a study of Pelargonium sidoides root extract EPs®7630 (Kaloba®) for the treatment of acute cough due to lower respiratory tract infection in adults—study protocol for a double blind, placebo-controlled randomised feasibility trial

HATRIC: a study of Pelargonium sidoides root extract EPs®7630 (Kaloba®) for the treatment of acute cough due to lower respiratory tract infection in adults—study protocol for a double blind, placebo-controlled randomised feasibility trial

Abstract Background Acute lower respiratory tract infection is a common acute infection managed in primary care. The current dominant management strategy in the UK is antibiotics, despite widespread publicity regarding antimicrobial resistance and evidence that the small benefits of antibiotics do n...

Description complète

Détails bibliographiques
Auteurs principaux: Amy Whitehead, Catherine Simpson, Merlin Willcox, Frances Webley, Alastair D. Hay, Chris Butler, Lily Yao, Emma Wrixon, Margaret Bell, Jennifer Bostock, Paul Little, Gareth Griffiths, Michael Moore
Format: Article
Langue:English
Publié: BMC 2019-07-01
Collection:Pilot and Feasibility Studies
Sujets:
Feasibility
Herbal
Double-blind randomised
Retention
Variance
Stratification
Accès en ligne:http://link.springer.com/article/10.1186/s40814-019-0478-6

Internet

http://link.springer.com/article/10.1186/s40814-019-0478-6

Documents similaires